Ronald Kirk Huntsman - 25 May 2021 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Executive Officer, Director
Signature: /s/ SEAN McKENDRY as attorney-in-fact for R. Kirk Huntsman
Issuer symbol: VVOS
Transactions as of: 25 May 2021
Net transactions value: +$21,520
Form type: 4
Filing time: 25 May 2021, 21:45:20 UTC
Previous filing: 29 Jun 2021
Next filing: 18 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VVOS	Common Stock	Purchase	$21,520	+4,000	+267%	$5.38^*	5,500	25 May 2021	Direct	F1
holding	VVOS	Common Stock						1,749,000	25 May 2021	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VVOS	Stock Option						333,334	25 May 2021	Common Stock	333,334	$1.65	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.335 to $5.40.
F2	Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
F3	The option provides for vesting in five equal annual installments beginning on January 15, 2017.